No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy-Reference-Cited by-同舟云学术

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

Published:2021-10-19 Issue: Volume: Page:
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Lajaunie Rébecca¹^ORCID,Cuzin Lise²^ORCID,Palich Romain³,Makinson Alain⁴^ORCID,Bani‐Sadr Firouzé⁵^ORCID,Duvivier Claudine⁶,Arvieux Cedric⁷,Rey David⁸,Poizot‐Martin Isabelle⁹,Delpierre Cyril¹⁰,Delobel Pierre¹¹,Martin‐Blondel Guillaume¹¹,Chirouze C.,Drobacheff‐Thiébaut C.,Foltzer A.,Bouiller K.,Hustache‐ Mathieu L.,Lepiller Q.,Bozon F.,Babre O,Brunel AS.,Muret P.,Chevalier E.,Jacomet C.,Laurichesse H.,Lesens O.,Vidal M.,Mrozek N.,Aumeran C.,Baud O.,Corbin V.,Goncalvez E.,Mirand A,Brebion A,Henquell C,Lamaury I.,Fabre I.,Curlier E.,Ouissa R.,Herrmann‐Storck C.,Tressieres B.,Receveur MC.,Boulard F.,Daniel C.,Clavel C.,Roger PM.,Markowicz S.,Chellum Rungen N.,Merrien D.,Perré P.,Guimard T.,Bollangier O.,Leautez S.,Morrier M.,Laine L.,Boucher D.,Point P.,Cotte L.,Ader F.,Becker A.,Boibieux A.,Brochier C.,Brunel‐Dalmas F.,Cannesson O.,Chiarello P.,Chidiac C.,Degroodt S.,Ferry T.,Godinot M.,Livrozet J.M.,Makhloufi D.,Miailhes P.,Perpoint T.,Perry M.,Pouderoux C.,Roux S.,Triffault‐Fillit C.,Valour F.,Charre C.,Icard V.,Tardy J.C.,Trabaud M.A.,Ravaux I.,Ménard A.,Belkhir AY.,Colson P.,Dhiver C.,Madrid A.,Martin‐Degioanni M.,Meddeb L.,Mokhtari M.,Motte A.,Raoux A.,Toméi C.,Tissot‐Dupont H.,Poizot‐Martin I.,Brégigeon S.,Zaegel‐Faucher O.,Obry‐Roguet V.,Laroche H,Orticoni M.,Soavi M.J.,Ressiot E.,Ducassou M.J.,Jaquet I.,Galie S.,Colson H.,Ritleng A.S.,Ivanova A.,Debreux C.,Lions C.,Rojas‐Rojas T,Cabié A.,Abel S.,Bavay J.,Bigeard B.,Cabras O.,Cuzin L.,Dupin de Majoubert R.,Fagour L.,Guitteaud K.,Marquise A.,Najioullah F.,Pierre‐François S.,Pasquier J.,Richard P.,Rome K.,Turmel JM,Varache C.,Atoui N.,Bistoquet M.,Delaporte E,Le Moing V.,Makinson A.,Meftah N.,Merle de Boever C.,Montes B.,Montoya Ferrer A.,Tuaillon E.,Reynes J.,Lefèvre B.,Jeanmaire E.,Hénard S.,Frentiu E.,Charmillon A.,Legoff A.,Tissot N.,André M.,Boyer L.,Bouillon MP.,Delestan M.,Goehringer F.,Bevilacqua S.,Rabaud C.,May T.,Raffi F.,Allavena C.,Aubry O.,Billaud E.,Biron C.,Bonnet B.,Bouchez S.,Boutoille D.,Brunet‐Cartier C.,Deschanvres C.,Gaborit B.J.,Grégoire A.,Grégoire M.,Grossi O.,Guéry R.,Jovelin T.,Lefebvre M.,Le Turnier P.,Lecomte R.,Morineau P.,Reliquet V.,Sécher S.,Cavellec M.,Paredes E.,Soria A.,Ferré V.,André‐Garnier E.,Rodallec A.,Pugliese P.,Breaud S.,Ceppi C.,Chirio D.,Cua E.,Dellamonica P.,Demonchy E.,De Monte A.,Durant J.,Etienne C.,Ferrando S.,Garraffo R.,Michelangeli C.,Mondain V.,Naqvi A.,Oran N.,Perbost I.,Carles M.,Klotz C.,Maka A.,Pradier C.,Prouvost‐Keller B.,Risso K.,Rio V.,Rosenthal E.,Touitou I.,Wehrlen‐Pugliese S.,Zouzou G.,Hocqueloux L.,Prazuck T.,Gubavu C.,Sève A.,Giaché S.,Rzepecki V.,Colin M.,Boulard C.,Thomas G.,Cheret A.,Goujard C.,Quertainmont Y.,Teicher E.,Lerolle N.,Jaureguiberry S.,Colarino R.,Deradji O.,Castro A.,Barrail‐Tran A.,Yazdanpanah Y.,Landman R.,Joly V.,Ghosn J.,Rioux C.,Lariven S.,Gervais A.,Lescure FX.,Matheron S.,Louni F.,Julia Z.,Le Gac S.,Charpentier C.,Descamps D.,Peytavin G.,Duvivier C.,Aguilar C.,Alby‐Laurent F.,Amazzough K.,Benabdelmoumen G.,Bossi P.,Cessot G.,Charlier C.,Consigny P.H.,Jidar K.,Lafont E.,Lanternier F.,Leporrier J.,Lortholary O.,Louisin C.,Lourenco J.,Parize P.,Pilmis B.,Rouzaud C.,Touam F.,Valantin MA.,Tubiana R.,Agher R.,Seang S.,Schneider L.,Palich R.,Blanc C.,Katlama C.,Bani‐Sadr F.,Berger JL.,N’Guyen Y.,Lambert D.,Kmiec I.,Hentzien M.,Brunet A.,Romaru J.,Marty H.,Brodard V.,Arvieux C.,Tattevin P.,Revest M.,Souala F.,Baldeyrou M.,Patrat‐Delon S.,Chapplain J.M.,Benezit F.,Dupont M.,Poinot M.,Maillard A.,Pronier C.,Lemaitre F.,Morlat C.,Poisson‐Vannier M.,Jovelin T.,Sinteff JP.,Gagneux‐Brunon A.,Botelho‐Nevers E.,Frésard A.,Ronat V.,Lucht F.,Rey D.,Fischer P.,Partisani M.,Cheneau C.,Priester M.,Batard ML.,Mélounou C,Bernard‐Henry C.,de Mautort E.,Fafi‐Kremer S.,Delobel P.,Alvarez M.,Biezunski N.,Debard A.,Delpierre C.,Gaube G.,Lansalot P.,Lelièvre L.,Marcel M.,Martin‐Blondel G.,Piffaut M.,Porte L.,Saune K.,Robineau O.,Ajana F.,Aïssi E.,Alcaraz I.,Alidjinou E.,Baclet V.,Bocket L.,Boucher A.,Digumber M.,Huleux T.,Lafon‐Desmurs B.,Meybeck A.,Pradier M.,Tetart M.,Thill P.,Viget N.,Valette M.,

Affiliation:

1. Department of Infectious and Tropical Diseases Toulouse University Hospital Toulouse France

2. Department of Infectious and Tropical Diseases Martinique University Hospital Fort de France FWI and INSERM UMR 1027 Toulouse III University Toulouse France

3. Sorbonne University Infectious Diseases Department Pitié‐Salpêtrière Hospital AP‐HP Pierre Louis Epidemiology and Public Health Institute (iPLESP) INSERM 1136 Paris France

4. Department of Infectious and Tropical Diseases Montpellier University Hospital InsermU1175 Montpellier France

5. Department of Infectious and Tropical Diseases Reims University Hospital 45, rue Cognacq‐Jay ‐ 51092 Reims Cedex Reims France

6. AP‐HP Necker Hospital Infectious Diseases Department Necker‐Pasteur Infectiology Center; IHU Imagine; Université de Paris; INSERM U1016 Institut Cochin; CNRS UMR8104; Institut Pasteur Medical Center of Institut Pasteur Necker‐Pasteur Infectiology Center Paris France

7. Department of Infectious and Tropical Diseases Rennes University Hospital 2 Rue Henri le Guilloux Rennes France

8. Department of Infectious and Tropical Diseases Strasbourg University Hospital Strasbourg France

9. Aix Marseille University INSERM IRD SESSTIM Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale Marseille France

10. Toulouse University Faculté de Médecine 37 Allées Jules Guesde Toulouse France

11. Department of Infectious and Tropical Diseases Toulouse University Hospital and INSERM UMR1291 ‐ CNRS UMR5051 – Université Toulouse III Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) Toulouse France

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13168

Reference20 articles.

1. HIV-Associated Cancers and Related Diseases

2. Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia

3. Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen

4. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor‐cell apoptosis associated with perturbation of proteasomal proteolysis;Gaedicke S;Cancer Res,2002

5. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection;Kowalkowski MA;Clin Infect Dis,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition;Cancers;2021-11-15